$3.950
+0.822 (+20.80%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de BCTX por análisis de gráficos similares
Alphio's BCTX stock price prediction model matches the current Briacell Therapeutics Corp tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.97 (+0.57%). The 1-week path is $4.03 (+1.91%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Briacell Therapeutics Corp?
Briacell Therapeutics Corp (BCTX) appears to be a good buy right now, primarily due to its recent price momentum and technical indicators. The stock has increased by 29.93% over the past five days and has a current price of $3.95, which is 12.9% of its 52-week range, suggesting potential for upward movement. Additionally, the RSI is at 75.981, indicating strong momentum, although it is approaching overbought territory. The company has also shown a significant increase in trading volume, with today's volume at 157,575, which is 2.67 times its 20-day average of 59,008, indicating heightened investor interest. However, the main risk is the company's ongoing financial losses, with a net income of -12,320,370 in the latest quarter, which could impact future performance.
BCTX cerró en $3.95 el Friday, tras subir +20.80%
Briacell Therapeutics Corp (BCTX) last closed at $3.95, gaining +20.80%. These facts feed the 1-day and 1-week BCTX price prediction above.
Factores de la previsión
Los factores de la previsión de Briacell Therapeutics Corp (BCTX) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bullish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de BCTX, ordenadas por similitud.
Análisis de estacionalidad de BCTX
Historically the probability of a positive November return for BCTX is 0.00%. January offers the highest probability of a positive month at 13.11%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de BCTX
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $0.96 | $0.96 | $1.04 | -75.60% |
| Dec 2026 | $0.75 | $0.76 | $0.91 | -80.73% |
En 2026, se proyecta que Briacell Therapeutics Corp (BCTX) oscile entre $0.75 y $1.04.
Previsión mensual de Briacell Therapeutics Corp para 2026
En Nov de 2026, se proyecta que Briacell Therapeutics Corp promedie $0.96, con un mínimo de $0.96 y un máximo de $1.04.
En Dec de 2026, se proyecta que Briacell Therapeutics Corp promedie $0.76, con un mínimo de $0.75 y un máximo de $0.91.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.